You are here

Asahi Kasei

Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024

BioSpace

Fri, 05/31/24 - 10:59 am

Numab Therapeutics

Calliditas Therapeutics

Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics

BioSpace

Tue, 05/28/24 - 10:34 pm

Calliditas Therapeutics

Diagnostics beat implants in the race to market

EP Vantage

Tue, 05/24/22 - 10:22 am

Lilly lands clinical-phase pain drug via deal with Asahi Kasei

Fierce Biotech

Thu, 01/28/21 - 10:51 am

neuroinflammatory pain

Veloxis wins $1.3B buyout deal, and the new owner plans to follow up with new deals

Endpoints

Tue, 11/26/19 - 09:47 am

Veloxis Pharmaceuticals

organ rejection

kidney transplants

Hypothetical Blockbuster Drug Leads To Very Real Blockbuster Verdict

Forbes

Wed, 01/29/14 - 05:45 pm

ThermoGenesis Announces Completion of CryoSeal(R) Product Line Transaction With Asahi

Wed, 08/22/12 - 10:44 pm

SEC closed probe of Zoll's Middle East sales just ahead of $2.3B Asahi merger

Tue, 05/15/12 - 07:06 pm

Asahi closes 2nd phase of $2.2B Zoll buyout

Thu, 04/26/12 - 10:22 pm

Rigrodsky & Long, P.A. Continues Investigation Regarding Acquisition of Zoll Medical Corporation by Asahi Kasei Corporation

Sat, 03/31/12 - 02:03 pm

Asahi Kasei Will Buy Zoll for $2.2 Billion to Expand in U.S. Health Care

Mon, 03/12/12 - 10:49 pm

Asahi Kasei of Japan to Buy Zoll Medical for $2.2 Billion

Mon, 03/12/12 - 10:28 pm

Actelion provides update on post-trial motions in Asahi Kasei litigation

Reuters

Sat, 07/30/11 - 10:17 am